Related Experiment Videos

Tuberculous meningitis in children during the isoniazid era

Insights

Tuberculous meningitis in children treated with isoniazid since 1952 resulted in significant long-term neurologic and social disabilities for survivors. Public health measures and chemoprophylaxis are crucial for disease elimination.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Neurology

Background:

  • Tuberculous meningitis (TBM) remains a significant cause of childhood mortality and morbidity.
  • The introduction of isoniazid in 1952 aimed to improve TBM treatment outcomes.

Observation:

  • A review of 59 pediatric cases of TBM at Charity Hospital, New Orleans, post-isoniazid introduction.
  • Analysis of in-hospital mortality, clinical recovery rates, and long-term sequelae in survivors.

Findings:

  • 14 out of 59 children died during hospitalization.
  • 21 children achieved complete or near-complete clinical recovery at discharge.
  • A significant proportion of long-term survivors (21 assessed) experienced notable neurologic and social disabilities.

Implications:

  • Despite advances in therapy, TBM continues to pose long-term challenges for pediatric survivors.
  • Understanding transmission dynamics, particularly from adult sources within households, is vital.
  • Emphasizes the critical role of chemoprophylaxis and robust public health strategies in TBM prevention and control.

Related Concept Videos